These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2960214)

  • 1. Active transport and cellular accumulation of cyclopentenone prostaglandins: a mechanism of prostaglandin-induced growth inhibition.
    Narumiya S; Fukushima M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():972-5. PubMed ID: 2960214
    [No Abstract]   [Full Text] [Related]  

  • 2. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
    Narumiya S; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.
    Narumiya S; Ohno K; Fukushima M; Fujiwara M
    J Pharmacol Exp Ther; 1987 Jul; 242(1):306-11. PubMed ID: 3302206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell growth inhibition by prostaglandins and its action mechanism].
    Narumiya S; Kato T; Fukushima M
    Seikagaku; 1985 Jul; 57(7):578-93. PubMed ID: 3906000
    [No Abstract]   [Full Text] [Related]  

  • 5. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
    Narumiya S; Ohno K; Fujiwara M; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):506-11. PubMed ID: 3772805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin D2, a potential antineoplastic agent.
    Fukushima M; Kato T; Ueda R; Ota K; Narumiya S; Hayaishi O
    Biochem Biophys Res Commun; 1982 Apr; 105(3):956-64. PubMed ID: 6953969
    [No Abstract]   [Full Text] [Related]  

  • 7. delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition.
    Narumiya S; Fukushima M
    Biochem Biophys Res Commun; 1985 Mar; 127(3):739-45. PubMed ID: 3857041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutathione content on cellular uptake and growth inhibitory activity of prostaglandin A2 in L-1210 cells.
    Ohno K; Hirata M; Narumiya S; Fukushima M
    Eicosanoids; 1992; 5(2):81-5. PubMed ID: 1449820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineoplastic action of prostaglandin D2--effect of PGD2 on proliferation of L1210 leukemic cells in culture].
    Fukushima M; Kato T; Ota K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):159-60. PubMed ID: 6964030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition.
    Ohno K; Fujiwara M; Fukushima M; Narumiya S
    Biochem Biophys Res Commun; 1986 Sep; 139(2):808-15. PubMed ID: 3464277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities.
    Fukushima M; Kato T; Ota K; Arai Y; Narumiya S; Hayaishi O
    Biochem Biophys Res Commun; 1982 Dec; 109(3):626-33. PubMed ID: 6961920
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of human gingival carcinoma cell growth by prostaglandins.
    Suzuki K; Kobayashi N; Moriya Y; Abiko Y; Suzuki H
    Gen Pharmacol; 1988; 19(2):273-6. PubMed ID: 3162424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antineoplastic prostaglandins].
    Fukushima M
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1930-5. PubMed ID: 6577812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of a prostaglandin A2-glutathione conjugate in L1210 mouse leukemia cells.
    Parker J; Ankel H
    Biochem Pharmacol; 1992 Mar; 43(5):1053-60. PubMed ID: 1554378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism.
    Hughes-Fulford M; Fukushima M
    Life Sci Adv Exp Clin Endocrinol; 1993; 12():57-64. PubMed ID: 11539936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
    Kato T; Fukushima M; Kurozumi S; Noyori R
    Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin D2: a neuromodulator.
    Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():333-7. PubMed ID: 6221610
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture.
    Bhuyan BK; Adams EG; Badiner GJ; Li LH; Barden K
    Cancer Res; 1986 Apr; 46(4 Pt 1):1688-93. PubMed ID: 3456266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
    Ohno K; Sakai T; Fukushima M; Narumiya S; Fujiwara M
    J Pharmacol Exp Ther; 1988 Apr; 245(1):294-8. PubMed ID: 3361448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modulation of human and murine melanoma growth by prostanoid analogues.
    Bregman MD; Meyskens FL
    Prostaglandins; 1983 Sep; 26(3):449-56. PubMed ID: 6581509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.